SCPHARMACEUTICALS INC. - COMMON STOCK

scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure

12 Jul 2022 08:00:02 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. to Host FUROSCIX® (furosemide) 80mg/10mL for Subcutaneous Administration Commercial Day: An Investigational Treatment for Heart Failure Patients

30 Jun 2022 08:00:02 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Abstracts Accepted for Presentation at the American Association of Heart Failure Nurses 18th Annual Meeting

07 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies Healthcare Conference

24 May 2022 08:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

17 May 2022 08:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports First Quarter 2022 Financial Results and Provides Business Update

16 May 2022 07:10:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces FDA Acceptance of FUROSCIX® New Drug Application

16 May 2022 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Resubmission of FUROSCIX® New Drug Application

11 Apr 2022 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

22 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the 42nd Annual Cowen Healthcare Conference

16 Feb 2022 16:05:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference

03 Feb 2022 08:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

20 Dec 2021 16:05:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

09 Nov 2021 07:00:02 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies London Healthcare Conference

02 Nov 2021 08:30:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Presents Late-breaking FREEDOM-HF Study Data at the Heart Failure Society of America Annual Scientific Meeting 2021

10 Sep 2021 08:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

01 Sep 2021 08:00:02 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update

11 Aug 2021 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Positive Top-Line Results from FREEDOM-HF Study

13 Jul 2021 16:08:26 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Receipt of Written Minutes from Type C Meeting with the FDA Regarding Development of FUROSCIX®

01 Jul 2021 08:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

19 May 2021 08:00:01 By Nasdaq GlobeNewswire